Independent Director Mr Vivek Dhariwal resigns effective Oct 12, 2026

Management Changes View source PDF Explain this filing

WINDLAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.7%Reaction day

₹930.00

prior close

₹930.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-2.4% vs market

Pharmaceuticals peers, median of 172sector+0.0%-1.7% vs sector

On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 1.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-0.8

15m

-1.6

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.7+0.7-2.4+0.0-1.7

Next day

-0.8-1.0+0.2-0.8+0.1

-1.9-0.3-1.6-0.6-1.3

-4.1-1.9-2.1-1.9-2.2

-4.6-4.5-0.1-3.5-1.1

-2.8-5.5+2.7-4.4+1.7

-4.9-7.3+2.4-4.3-0.6

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr Vivek Dhariwal has resigned as Independent Director of Windlas Biotech, effective close of business on October 12, 2026, citing personal reasons and prior commitments. He also stepped down as Chairman of the Board and as a member of the Nomination and Remuneration Committee and CSR Committee. He holds no directorships in other listed companies and confirmed there are no other material reasons for his exit.

Likely market impact

Board loses its Chairman and an Independent Director. Company must appoint a replacement and new Chairman; watch for the next board update.